Over the past year, SIP quickened its pace to pursue new industrialization and high-quality development relying on its market-oriented, enterprise-driven, product-centered innovation ecosystem.

The local pillar industries achieved significant progress. By the end of 2025, SIP had gathered more than 1,800 companies engaged in AI and digital technology, with an output value totaling RMB110 billion, a year-on-year increase of about 10%. AI technology had been widely used in manufacturing, research, administrative services, medical care, financial services, cultural tourism and other fields.

Moreover, cutting-edge AI solutions are driving a boom of one-person companies (OPCs), a new form of entrepreneurship.

The biomedical and healthcare sectors also saw remarkable achievements, with a number of new drugs and medical devices coming into market. Since 2006, SIP has gathered over 2,000 companies specializing in innovative drugs, high-end medical devices and healthcare, leading nationwide in terms of comprehensive competitiveness of these industries.

To better support tech companies, SIP is crafting the “623” industrial system which features six major industrial clusters and 23 key industry chains, offering preferential policies and tailored support to help companies within the system grow fast. In December 2025, Suzhou Novosense Microelectronics Co Ltd went public on the Main Board of the HKEX, becoming the 72nd listed company in SIP.

In 2026, SIP aims to deepen innovative integration of AI and real economy, optimize the innovation ecosystem for OPCs, enhance support for talents and investors and spare no effort to help companies grow stronger.

January 6, 2026